Evonik Evonik

X

CAS 288-88-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 288-88-0
Also known as: 1h-1,2,4-triazole, 288-88-0, 4h-1,2,4-triazole, Pyrrodiazole, S-triazole, 1,2,4-1h-triazole
Molecular Formula
C2H3N3
Molecular Weight
69.07  g/mol
InChI Key
NSPMIYGKQJPBQR-UHFFFAOYSA-N
FDA UNII
10MS0Y1RDI

1 2D Structure

CAS 288-88-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1H-1,2,4-triazole
2.1.2 InChI
InChI=1S/C2H3N3/c1-3-2-5-4-1/h1-2H,(H,3,4,5)
2.1.3 InChI Key
NSPMIYGKQJPBQR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=NC=NN1
2.2 Other Identifiers
2.2.1 UNII
10MS0Y1RDI
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1,2,4-triazole, Potassium Salt

2.3.2 Depositor-Supplied Synonyms

1. 1h-1,2,4-triazole

2. 288-88-0

3. 4h-1,2,4-triazole

4. Pyrrodiazole

5. S-triazole

6. 1,2,4-1h-triazole

7. 63598-71-0

8. Mfcd00005228

9. Nsc 83128

10. Dtxsid6027131

11. Peptone, Bacteriological

12. 1h-[1,2,4]triazole

13. 10ms0y1rdi

14. Chebi:46077

15. Nsc-83128

16. (1,2,4)-triazole

17. [1,2,4]-triazole

18. 736917-78-5

19. 1,2,4 Triazole

20. 1h-1,2,4-triazol

21. 1,2,4-triazol

22. 4h-1,2,4-triazole (van)

23. Einecs 206-022-9

24. Unii-10ms0y1rdi

25. Ai3-51031

26. Hsdb 7860

27. 1,4-triazole

28. 1,2,4triazole

29. 1,3,4-triazole

30. 1h-1,4-triazole

31. 4h-1,4-triazole

32. [1,2,4]triazole

33. 1,2, 4-triazole

34. 1,2,4,-triazole

35. [1,2,4]triazol

36. [1.2.4]-triazole

37. 1, 2, 4 Triazole

38. [1,2,4]-triazol

39. 1,2,4-1h Triazole

40. Dsstox_cid_7131

41. Ec 206-022-9

42. 4h-[1,2,4]triazole

43. Dsstox_rid_78318

44. Dsstox_gsid_27131

45. 1h-[1,2,4]-triazole

46. Chembl15571

47. 1,2,4-triazole, 98%

48. Niosh/xz3807000

49. Chebi:35550

50. Efinaconazole Metabolite H1

51. Amy40414

52. Bcp20885

53. Cs-d1150

54. Nsc83128

55. Triazole, 1h,1,2,4-

56. Zinc5943507

57. Tox21_300113

58. Cga-71019

59. Mfcd01941334

60. Stk366100

61. 1,2,4-triazole, Analytical Standard

62. 1h-1,2,4-triazole [mi]

63. Akos000120326

64. Akos000269054

65. 1h-1,2,4-triazole [hsdb]

66. Db03594

67. Ps-9377

68. Ncgc00247903-01

69. Ncgc00254087-01

70. Bp-12667

71. Cas-288-88-0

72. Sy001414

73. Db-002017

74. Bb 0267986

75. Cs-0368547

76. Ft-0607865

77. T0340

78. Xz38070000

79. 88t880

80. E76126

81. T-6200

82. 1,2,4-triazole, Vetec(tm) Reagent Grade, 98%

83. A819652

84. Q161300

85. F1918-0085

86. Z1245636363

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 69.07 g/mol
Molecular Formula C2H3N3
XLogP3-0.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass69.032697108 g/mol
Monoisotopic Mass69.032697108 g/mol
Topological Polar Surface Area41.6 Ų
Heavy Atom Count5
Formal Charge0
Complexity28.1
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 Absorption, Distribution and Excretion

After a single oral administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx 100% of the (14)C activity was absorbed from the digestive tract.

European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/


8 hr after a single iv administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx 50% of the applied radioactivity was detectable in the body of the animals (gastrointestinal tract not considered). 3 days after the application approx 1.5% of the applied activity could be found, and after 6 days the (14)C-activity was no longer measurable (detection limit 0.3%).

European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/


Following a single oral or iv administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx. 0.1% of the (14)C-activity was exhaled within 30 hr.

European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/


1H-1,2,4-Triazole (14)C-labeled was administered to male rats orally (dose: 1 mg/kg bw) or iv (doses: 0.1, 1, 10, 100 mg/kg bw). Within 48 hr after the single application 92-94% of the (14)C-activity was excreted with the urine and 3-5% with the feces, regardless whether the substance was applied orally or iv.

European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/


For more Absorption, Distribution and Excretion (Complete) data for 1H-1,2,4-Triazole (6 total), please visit the HSDB record page.


Flag India
Digital Content Digital Content
288-88-0
1H-1,2,4-Triazole
Chynops Pharma, a company certified with ISO 9001:2015, is situated in Ahmedabad, India. We specialize in...
Chynops Pharma, a company certified with ISO 9001:2015, is situated in Ahmedabad, India. We specialize in exporting, supplying, and trading a wide range of products, including APIs, Advanced Drug Intermediates, Impurity Standards, Working Standards, KSMs, Industrial Chemicals, Specialty Chemicals, Excipients, Amino Acids, Vitamins, Minerals, Herbal Extracts, Essential Oils, Prebiotics & Probiotics, Veterinary APIs, Solvents, and more from India. Our commitment extends to providing these products to valued customers in both the domestic and global markets.
Chynops Pharma

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
288-88-0
1-H 1,2,4 TRIAZOLE
Riddhi Pharma was set up in 1997 as a Manufacturer of API’s Intermediates and Fine Chemicals, especiall...
Riddhi Pharma was set up in 1997 as a Manufacturer of API’s Intermediates and Fine Chemicals, especially in the field of Friedel Crafts Reaction / Bromination and Chlorination. The establishment of the company itself was motivated by a strong desire to provide Quality Bulk API’s Intermediates in the most cost-effective way. Right our inception, we are focused on exploiting the potential of the Pharmaceutical Industry and our articulate vision has made us a significant player in Bulk API’s Sector.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
288-88-0
1H-1,2,4-Triazole
Shreenath Chemicals stands as a prominent producer of bulk drugs, drug intermediates, and fine chemicals....
Shreenath Chemicals stands as a prominent producer of bulk drugs, drug intermediates, and fine chemicals. Operating from two advanced manufacturing facilities located in M.I.D.C. Tarapur Boisar, Maharashtra, the company boasts audit-friendly units endorsed by numerous global clients. These facilities strictly adhere to international quality standards, holding GMP and ISO 9001:2015 certifications.Established in 1989, Shreenath Chemicals has expanded its services to cater to over 650 Pan-Asian manufacturers of finished formulations and active pharmaceutical ingredient traders, earning high customer satisfaction.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY